PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.
Saved in:
| Title: | PRMT5: An Emerging Target for Pancreatic Adenocarcinoma. |
|---|---|
| Authors: | Lee MKC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; The University of Melbourne Centre for Cancer Research, Parkville, VIC 3010, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Grimmond SM; The University of Melbourne Centre for Cancer Research, Parkville, VIC 3010, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia. |
| Source: | Cancers [Cancers (Basel)] 2021 Oct 13; Vol. 13 (20). Date of Electronic Publication: 2021 Oct 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
